(Q71067347)
Statements
Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma (English)
T M Law
R J Motzer
M Mazumdar
K W Sell
P J Walther
M O'Connell
A Khan
V Vlamis
N J Vogelzang
1 September 1995